Effects of celecoxib on ionic currents and spontaneous firing in rat retinal neurons

Abstract Accumulating evidence suggests that the side effects of celecoxib, widely used to treat muscle and joint pain, may be mediated in part through cyclooxygenase-2 (COX-2) independent mechanisms, such as inhibition of ion channels. In this study we report effects of celecoxib on ionic currents...

Full description

Saved in:
Bibliographic Details
Published inNeuroscience Vol. 154; no. 4; pp. 1525 - 1532
Main Authors Frolov, R.V, Slaughter, M.M, Singh, S
Format Journal Article
LanguageEnglish
Published Oxford Elsevier Ltd 17.07.2008
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Abstract Accumulating evidence suggests that the side effects of celecoxib, widely used to treat muscle and joint pain, may be mediated in part through cyclooxygenase-2 (COX-2) independent mechanisms, such as inhibition of ion channels. In this study we report effects of celecoxib on ionic currents and neuronal activity in isolated rat retinal neurons. We found that celecoxib suppressed voltage-gated potassium currents in retinal bipolar cells with an effective concentration to inhibit 50% of function (EC50 ) of 5.5 μM. In retinal amacrine and ganglion cells, celecoxib inhibited voltage-dependent sodium channels with an EC50 of 5.2 μM, and voltage-dependent transient and sustained potassium currents with EC50 s of 16.3 and 9.1 μM, respectively. Notably, the rate of spontaneous spike activity was dramatically suppressed in ganglion and amacrine cells with an EC50 of 0.76 μM. All actions of celecoxib on ionic currents and action potentials occurred from the extracellular side and were completely reversible. These findings indicate that inhibition of ion channels by celecoxib in the CNS may affect neuronal function at clinically relevant concentrations.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ISSN:0306-4522
1873-7544
DOI:10.1016/j.neuroscience.2008.05.004